Randomized Trial of Maternal Progesterone Therapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT02133573

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02133573
Other papers using this trial's data
  • Progesterone for Neurodevelopment in Fetuses With Congenital Heart Defects: A Randomized Clinical Trial JAMA network open, 2024-05-01 DOI, PubMed 38805228, PMC11134212 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02133573. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2021-11 (actual). Results posted on 2023-02-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial of Maternal Progesterone Therapy
Condition
Congenital Heart Disease
Condition
Periventricular Leucomalacia
Condition
Brain Development
Condition
Cardiac Surgery
Condition
Neurodevelopmental Disability
Condition
Fetal Neuroprotection
Intervention (Drug)
Progesterone
Intervention (Drug)
Vaginal lubricant
Lead sponsor
Children's Hospital of Philadelphia (class: other)

Record details

Record id
cardio:ct-nct02133573
Content hash
52245d0371a8c71a395447d6d9cd74a0a447d17c48f710d55c8d04edcce147f6